We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Failure of Furazolidone Therapy in Shigellosis

Kenneth C. Haltalin, MD; John D. Nelson, MD
Am J Dis Child. 1972;123(1):40-44. doi:10.1001/archpedi.1972.02110070090011.
Text Size: A A A
Published online


Dilution susceptibility testing of 139 Shigella isolates from patients with acute shigellosis showed that all were inhibited by concentrations of 2.5μg of furazolidone per milliliter, with the majority being inhibited by 0.625μg/ml or less. Nineteen infants and children hospitalized for severe shigellosis were treated with 8 mg/kg/day of furazolidone for five days. Persistence of positive stool cultures for more than 48 hours or relapse after initial bacteriologic response was observed in 13 patients (68%). Clinical failure occurred in eight patients (42%). There was no decrease in the numbers of Shigella per gram of feces shed during therapy compared with pretreatment quantitations. The clinical and bacteriologic results of furazolidone therapy are comparable to the natural course of illness seen in placebo-treated patients and markedly inferior to those obtained with ampicillin therapy. On the basis of these findings and a review of previous reports we conclude that furazolidone is ineffective and should not be recommended for treating shigellosis.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.